Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T00:49:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T20:45:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T15:22:12.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T02:20:01.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T14:19:52.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 27, 2025.
    Difference
    1.0%
    Check dated 2025-04-09T09:05:11.000Z thumbnail image

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.